팬젠 둜고

팬젠 (222110) μ£Όκ°€ 및 μ’…λͺ© 정보

팬젠 μ‹€μ‹œκ°„ μ£Όκ°€

ν˜„μž¬κ°€ 6,440 원
λ³€λ™λŸ‰ β–² 20.00 원
변동λ₯  0.31%
κ±°λž˜λŸ‰ 30,643
κ±°λž˜λŒ€κΈˆ 192,075,260 원

팬젠 일별 μ£Όκ°€

팬젠의 κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
5/18/2025 6,060 6,120 5,710 5,770 30,043 175,256,070
5/19/2025 5,770 6,000 5,740 5,970 11,458 67,277,230
5/20/2025 5,970 6,210 5,940 6,020 21,600 130,357,160
5/21/2025 5,970 6,050 5,940 6,040 6,487 38,866,380
5/22/2025 6,060 6,060 5,840 5,880 8,486 50,154,440
5/25/2025 5,880 5,960 5,520 5,660 34,989 198,447,620
5/26/2025 5,660 6,490 5,500 6,480 86,674 531,489,775
5/27/2025 6,550 6,760 6,330 6,460 62,941 410,999,950
5/28/2025 6,470 6,640 6,220 6,420 24,009 153,504,800
5/29/2025 6,420 6,500 6,110 6,440 30,643 192,075,260

κ΄€λ ¨ ν…Œλ§ˆ

  • λ°”μ΄μ˜€μ‹œλ°€λŸ¬ : λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆ 개발, 제쑰 μ—…μ²΄λ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆμ€ EPO(빈혈 치료제), Factor VIII(ν˜ˆμš°λ³‘A 치료제) 및 G-CSF(ν•­μ•”μΉ˜λ£Œ 보쑰제) μ œν’ˆμ„ 순차적으둜 개발 쀑
  • 혈μž₯치료 : ν˜ˆμš°λ³‘ μΉ˜λ£Œμ œμ™€ λ‹€μ–‘ν•œ ν˜ˆμ•‘ κ΄€λ ¨ 치료제λ₯Ό κ°œλ°œν•΄ 혈μž₯ 치료 관련주에 νŽΈμž…

팬젠 νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 869μ–΅ 878μœ„ 13,494,197 7.29% ν—¬μŠ€μΌ€μ–΄ 생λͺ…κ³Όν•™/곡학 7,770 3,750

팬젠 κΈ°μ—… κ°œμš”

νŒ¬μ  μ€ 2010λ…„ 1μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆμ˜ 생산 및 판맀, λ°”μ΄μ˜€μ˜μ•½ν’ˆ 개발, λ°”μ΄μ˜€μ˜μ•½ν’ˆ μœ„νƒμƒμ‚° 및 개발기술 μ΄μ „μ„œλΉ„μŠ€ λ“±μ˜ 사업을 μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ EPO μ˜μ•½ν’ˆ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” λ§Œμ„± μ‹ λΆ€μ „ ν™˜μžμ˜ 빈혈 치료제인 λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆ 자체 μ œν’ˆκ°œλ°œμ— μ„±κ³΅ν•˜μ—¬ κ΅­λ‚΄ 및 λ§λ ˆμ΄μ‹œμ•„ μ‹œμž₯μ—μ„œ 판맀 쀑에 있으며 κ·Έ 밖에 λ‹€μ–‘ν•œ λ°”μ΄μ˜€ μ˜μ•½ν’ˆμ„ 개발 쀑에 μžˆλ‹€.

팬젠 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 14,672,686,810 100.58% 1,020,165,959 124.14% 943,686,868 121.02%
2023.4Q 7,315,125,370 12.53% -4,225,497,054 7.95% -4,488,830,770 0.11%
2022.4Q 6,500,658,000 -18.08% -4,590,629,400 -39.60% -4,493,832,000 -35.75%
2021.4Q 7,935,565,000 28.18% -3,288,356,900 11.13% -3,310,318,300 24.01%

팬젠 νˆ¬μžμžλ³„ 맀맀동ν–₯

μˆœλ§€μˆ˜λŸ‰

개인: -6,051

κΈ°κ΄€: -5

외인: 6,056

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: 129,987

κΈ°κ΄€: -145,160

외인: 15,173

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-05-30 -6,051 -5 6,056
2025-05-29 5,710 -13 -5,697
2025-05-28 6,104 -409 -5,695
2025-05-27 -6,709 -2,177 8,886
2025-05-26 -2,645 690 1,955
2025-05-23 1,301 -106 -1,195
2025-05-22 506 -444 -62
2025-05-21 -1,833 540 1,293
2025-05-20 -2,099 -483 2,582
2025-05-19 -2,885 439 2,446
2025-05-16 -1,975 - 1,975
2025-05-15 -689 -645 1,334
2025-05-14 5,187 -7,381 2,194
2025-05-13 5,751 -500 -5,251
2025-05-12 3,173 - -3,173
2025-05-09 1,145 - -1,145
2025-05-08 -3,973 - 3,973
2025-05-07 -3,798 - 3,798
2025-05-02 2,804 - -2,804
2025-04-30 735 - -735
2025-04-29 -888 - 888

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-05-30 -1,129 -10,494 11,623
2025-05-29 4,922 -10,489 5,567
2025-05-28 -788 -10,476 11,264
2025-05-27 -6,892 -10,067 16,959
2025-05-26 -183 -7,890 8,073
2025-05-23 2,462 -8,580 6,118
2025-05-22 1,161 -8,474 7,313
2025-05-21 655 -8,030 7,375
2025-05-20 2,488 -8,570 6,082
2025-05-19 4,587 -8,087 3,500
2025-05-16 7,472 -8,526 1,054
2025-05-15 9,447 -8,526 -921
2025-05-14 10,136 -7,881 -2,255
2025-05-13 4,949 -500 -4,449
2025-05-12 -802 - 802
2025-05-09 -3,975 - 3,975
2025-05-08 -5,120 - 5,120
2025-05-07 -1,147 - 1,147
2025-05-02 2,651 - -2,651
2025-04-30 -153 - 153
2025-04-29 -888 - 888

팬젠 μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
30,906,891,811 17.03% 82.97%

팬젠 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO [EPOμ˜μ•½ν’ˆ] 46.6%
μœ„νƒμƒμ‚°(CMO) 21.8%
기타 13.3%
κΈ°μˆ μ΄μ „(CDO) 13.2%
λ‘œμ—΄ν‹° 3.7%
μƒν’ˆ 1.4%

팬젠 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 220 (0.72%)

졜근 곡맀도 μž”κ³ : 0 (0%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2025-05-30 6,440 220 0.72%
2025-05-29 6,420 1,107 4.61%
2025-05-28 6,460 48 0.08%
2025-05-27 6,480 0 0.00%
2025-05-26 5,660 11 0.03%
2025-05-23 5,880 68 0.80%
2025-05-22 6,040 0 0.00%
2025-05-21 6,020 1,311 6.07%
2025-05-20 5,970 3,605 31.46%
2025-05-19 5,770 1,145 3.81%
2025-05-16 6,100 1,156 3.57%
2025-05-15 6,110 721 3.57%
2025-05-14 6,000 442 1.14%
2025-05-13 6,070 2,502 5.86%
2025-05-12 5,800 782 3.96%
2025-05-09 5,790 2,650 8.27%
2025-05-08 5,600 1,167 6.10%
2025-05-07 5,640 0 0.00%
2025-05-02 5,700 0 0.00%
2025-04-30 5,800 154 0.88%
2025-04-29 5,680 442 8.30%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2025-05-28 6,460 0 0.00%
2025-05-27 6,480 0 0.00%
2025-05-26 5,660 0 0.00%
2025-05-23 5,880 0 0.00%
2025-05-22 6,040 0 0.00%
2025-05-21 6,020 0 0.00%
2025-05-20 5,970 0 0.00%
2025-05-19 5,770 0 0.00%
2025-05-16 6,100 0 0.00%
2025-05-15 6,110 0 0.00%
2025-05-14 6,000 0 0.00%
2025-05-13 6,070 0 0.00%
2025-05-12 5,800 0 0.00%
2025-05-09 5,790 0 0.00%
2025-05-08 5,600 0 0.00%
2025-05-07 5,640 0 0.00%
2025-05-02 5,700 0 0.00%
2025-04-30 5,800 0 0.00%
2025-04-29 5,680 0 0.00%
2025-04-28 5,680 0 0.00%
2025-04-25 5,660 0 0.00%

팬젠 μ—…μ’… λ‚΄ 비ꡐ

생λͺ…κ³Όν•™/곡학 μ—…μ’…(90개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© 팬젠 μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 866.327 7,202.97 61μœ„
PER(졜근4λΆ„κΈ°) 77.043 19.58 5μœ„
PBR - - -μœ„
ROE(졜근4λΆ„κΈ°) 5.036 -33.99 18μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) 6.953 -1,687.54 15μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) 6.432 -1,609.8 18μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 22.626 72.31 63μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 146.727 477.59 33μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) 10.202 -85.98 16μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) 9.437 -72.57 22μœ„